Increased mortality associated with growth hormone treatment in critically ill adults

New England Journal of Medicine

Volumn 341, Issue 11, 1999, Pages 785-792

  Takala, Jukka ^a   Ruokonen, Esko ^a   Webster, Nigel R ^b   Nielsen, Michael S ^c   Zandstra, Durk F ^d   Vundelinckx, Guy ^e   Hinds, Charles J ^f  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e St Jans Hospital   (Belgium)

^f ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; FEMALE; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MALE; METABOLIC DISORDER; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; HOSPITAL MORTALITY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTENSIVE CARE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDIES; RISK; SHOCK, SEPTIC;

EID: 0033539018     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199909093411102     Document Type: Article

References (40)

1. Rennie MJ. Muscle protein turnover and the wasting due to injury and disease. Br Med Bull 1985;41:257-64.
2. Arnold J, Campbell IT, Samuels TA, et al. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci (Colch) 1993;84:655-61. [Erratum, Clin Sci (Colch) 1993;85:xxva.]
3. Ross R, Miell J, Freeman E, et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 1991;35: 47-54.
4. Van den Berghe G, De Zegher F, Veldhuis JD, et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab 1997;82:590-9.
5. Timmins AC, Cotterill AM, Hughes SC, et al. Critical illness is associated with low circulating concentrations of insulin-like growth factors-1 and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 1996;24:1460-6.
6. Manson JM, Smith RJ, Wilmore DW. Growth hormone stimulates protein synthesis during hypocaloric patenteral nutrition: role of hormonal-substrate environment. Ann Surg 1988;208:136-42.
7. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg 1991;126:38-43.
8. Jeevanandam M, Ali MR, Holiday NJ, Petersen SR. Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. JPEN J Parenter Enteral Nutr 1995;19:137-44.
9. Ziegler TR, Rombeau JL, Young LS, et al. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab 1992;74:865-73.
10. Ponting GA, Halliday D, Teale JD, Sim AJW. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988;1:438-40.
11. Voerman HJ, van Schijndel RJM, Groeneveld ABJ, et al. Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg 1992;216:648-55.
12. Voerman BJ, Strack van Schijndel RJM, Groeneveld AB, de Boer H, Nauta JP, Thijs LG. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit Care Med 1995;23:665-73.
13. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;212:424-9.
14. Hammarqvist F, Stromberg C, von der Decken A, Vinnars E, Wernerman J. Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle-free glutamine, and improves whole-body nitrogen economy after operation. Ann Surg 1992;216:184-91.
15. Jiang Z-M, He G-Z, Zhang S-Y, et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989;210:513-25.
16. Knox JB, Wilmore DW, Demling RH, Sarraf P, Santos AA. Use of growth hormone for postoperative respiratory failure. Am J Surg 1996;171: 576-80.
17. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991;99:1495-500.
18. Suchner U, Rothkopf MM, Stanislaus G, Elwyn DH, Kvetan V, Askanazi J. Growth hormone and pulmonary disease: metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 1990;150:1225-30.
19. Pichard C, Kyle U, Chevrolet J-C, et al. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study. Crit Care Med 1996;24:403-13.
20. Malstam J, Lind L. Therapeutic Intervention Scoring System (TISS) - a method for measuring workload and calculating costs in the ICU. Acta Anaesthesiol Scand 1992;36:758-63.
21. Christensen T, Bendix T, Kehlet H. Fatigue and cardiorespiratory function following abdominal surgery. Br J Surg 1982;69:417-9.
22. Ruokonen E, Takala J, Kari A, Alhava E. Septic shock and multiple organ failure. Crit Care Med 1991;19:1146-51.
23. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993;19:323-8.
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
25. 2. J Immunol 1995;154:1909-18.
26. Edwards CK III, Lorence RM, Dunham DM, et al. Hypophysectomy inhibits the synthesis of tumor necrosis factor a by rat macrophages: partial restoration by exogenous growth hormone or interferon γ. Endocrinology 1991;128:989-96.
27. Kappel M, Hansen MB, Diamant M, Pedersen BK. In vitro effects of human growth hormone on the proliferative responses and cytokine production of blood mononuclear cells. Horm Metab Res 1994;26:612-4.
28. Elsasser TH, Fayer R, Rumsey TS, Hartnell GF. Recombinant bovine somatotropin blunts plasma tumour necrosis factor-α, cortisol, and thromboxane-B2 responses to endotoxin in vivo. Endocrinology 1994;134:1082-8.
29. Inoue T, Saito H, Fukushima R, et al. Growth hormone and insulin-like growth factor I enhance host defense in a murine sepsis model. Arch Surg 1995;130:1115-22.
30. Liao W, Rudling M, Angclin B. Growth hormone potentiates the in vivo biological activities of endotoxin in the rat. Eur J Clin Invest 1996; 26:254-8.
31. Vara-Thorbeck R, Guerrero JA, Rosell J, Ruiz-Requena E, Capitan JM. Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function. World J Surg 1993;17:530-8.
32. Gottardis M, Benzer A, Koller W, Luger TJ, Puhringer F, Hackl J. Improvement of septic syndrome after administration of recombinant human growth hormone (rhGH)? J Trauma 1991;31:81-6.
33. Gatzen C, Scheltinga MR, Kimbrough TD, Jacobs DO, Wilmore DW. Growth hormone attenuates the abnormal distribution of body water in critically ill surgical patients. Surgery 1992;112:181-7.
34. Biolo G, Iscra F, Toigo G, et al. Effects of growth hormone adminis-tration on skeletal muscle glutamine metabolism in severely traumatized patients: preliminary report. Clin Nutr 1997;16:89-91.
35. Jeevanandam M, Petersen SR. Altered lipid kinetics in adjuvant recombinant human growth hormone-treated multiple-trauma patients. Am J Physiol 1994;267:E560-E565.
36. Gelding SV, Taylor NF, Wood PJ, et al. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity. Clin Endocrinol (Oxf) 1998;48:153-62.
37. Koea JB, Breier BH, Douglas RG, Gluckman PD, Shaw JHF. Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis. Br J Surg 1996;83:196-202.
38. Voerman BJ, Strack van Schijndel RJ, de Boer H, et al. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. J Crit Care 1994;9:143-50.
39. Knox J, Demling R, Wilmore D, Sarraf P, Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma 1995;39:526-30.
40. Tacke J, Bolder U, Lohlein D. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery. Infusionsther Transfusionsmed 1994; 21:24-9.